Recovery of negative-strand RNA viruses from plasmid DNAs: A positive approach revitalizes a negative field

Virology

Volumn 247, Issue 1, 1998, Pages 1-6

  Roberts, Anjeanette ^a   Rose, John K ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLASMID DNA; VIRUS RNA;

IMMUNIZATION; INFECTION PREVENTION; NONHUMAN; PRIORITY JOURNAL; RNA VIRUS; SHORT SURVEY; VIRUS GENOME; VIRUS INFECTION; VIRUS REPLICATION;

ANIMALIA; DNA VIRUSES; RNA VIRUSES;

EID: 0032551695     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1998.9250     Document Type: Short Survey

References (36)

1. Baron M. D., Barrett T. Rescue of rinderpest virus from cloned cDNA. J. Virol. 71:1997;1265-1271.
2. Bridgen A., Elliott R. M. Rescue of a segmented negative-strand RNA virus entirely from cloned complementary DNAs. Proc. Natl. Acad. Sci. USA. 93:1996;15400-15404.
3. Bukreyev A., Camargo E., Collins P. L. Recovery of infectious respiratory syncytial virus expressing an additional, foreign gene. J. Virol. 70:1996;6634-6641.
4. Collins P. L., Hill M. G., Camargo E., Grosfeld H., Chanock R. M., Murphy B. R. Production of infectious human respiratory syncytial virus from cloned cDNA confirms an essential role for the transcription elongation factor from the 5′ proximal open reading frame of the M2 mRNA in gene expression and provides a capability for vaccine development. Proc. Natl. Acad. Sci. USA. 92:1995;11563-11567.
5. Durbin A. P., Hall S. L., Siew J. W., Whitehead S. S., Collins P. L., Murphy B. R. Recovery of infectious human parainfluenza virus type 3 from cDNA. Virology. 235:1997;323-332.
6. Enami M., Luytjes W., Krystal M., Palese P. Introduction of site-specific mutations into the genome of influenza virus. Proc. Natl. Acad. Sci. USA. 87:1990;3802-3805.
7. Garcin D., Pelet T., Calain P., Roux L., Curran J., Kolakofsky D. A highly recombinogenic system for the recovery of infectious Sendai paramyxovirus from cDNA: Generation of a novel copy-back nondefective interfering virus. EMBO J. 14:1995;6087-6094.
8. Hasan M. K., Kato A., Shioda T., Sakai Y., Yu D., Nagai Y. Creation of an infectious recombinant Sendai virus expressing the firefly luciferase gene from the 3′ proximal first locus. J. Gen. Virol. 78:1997;2813-2820.
9. He B., Paterson R. G., Ward C. D., Lamb R. A. Recovery of infectious SV5 from cloned DNA and expression of a foreign gene. Virology. 237:1997;249-260.
10. Hoffman M. A., Banerjee A. K. An infectious clone of human parainfluenza virus type 3. J. Virol. 71:1997;4272-4277.
11. Iverson L. E., Rose J. K. Localized attenuation and discontinuous synthesis during vesicular stomatitis virus transcription. Cell. 23:1981;477-484.
12. Jin H., Subbarao K., Bagai S., Leser G. P., Murphy B. R., Lamb R. A. Palmitylation of the influenza virus hemagglutinin (H3) is not essential for virus assembly or infectivity. J. Virol. 70:1996;1406-1414.
13. Johnson J. E., Schnell M. J., Buonocore L., Rose J. K. Specific targeting to CD4+ cells of recombinant vesicular stomatitis viruses encoding human immunodeficiency virus envelope proteins. J. Virol. 71:1997;5060-5068.
14. Kato A., Sakai Y., Shioda T., Kondo T., Nakanishi M., Nagai Y. Initiation of Sendai virus multiplication from transfected cDNA or RNA with negative or positive sense. Genes Cells. 1:1996;569-579.
15. Kato A., Kiyotani K., Sakai Y., Yoshida T., Nagai Y. The paramyxovirus, Sendai virus, V protein encodes a luxury function required for viral pathogenesis. EMBO J. 16:1997;578-587.
16. Kretzschmar E., Buonocore L., Schnell M. J., Rose J. K. High-efficiency incorporation of functional influenza virus glycoproteins into recombinant vesicular stomatitis viruses. J. Virol. 71:1997;5982-5989.
17. Kretzschmar E., Peluso R., Schnell M. J., Whitt M. A., Rose J. K. Normal replication of vesicular stomatitis virus without C proteins. Virology. 216:1996;309-316.
18. Kurotani A., Kiyotani K., Kato A., Shioda T., Sakai Y., Mizumoto K., Yoshida T., Nagai Y. Sendai virus C proteins are categorically nonessential gene products but silencing their expression impairs viral replication and pathogenesis. Genes Cells. 3:1998;111-124.
19. Lawson N. D., Stillman E. A., Whitt M. A., Rose J. K. Recombinant vesicular stomatitis viruses from DNA [published Erratum appears inProc Natl Acad Sci USA92. Proc. Natl. Acad. Sci. USA. 92:1995;4477-4481.
20. Luytjes W., Krystal M., Enami M., Pavin J. D., Palese P. Amplification, expression, and packaging of foreign gene by influenza virus. Cell. 59:1989;1107-1113.
21. Mebatsion T., Schnell M. J., Cox J. H., Finke S., Conzelmann K. K. Highly stable expression of a foreign gene from rabies virus vectors. Proc. Natl. Acad. Sci. USA. 93:1996;7310-7314.
22. Palese P., Zheng H., Engelhardt O. G., Pleschka S., Garcia-Sastre A. Negative-strand RNA viruses: Genetic engineering and applications. Proc. Natl. Acad. Sci. USA. 93:1996;11354-11358.
23. Pleschka S., Jaskunas R., Engelhardt O. G., Zurcher T., Palese P., Garcia-Sastre A. A plasmid-based reverse genetics system for influenza A virus. J. Virol. 70:1996;4188-4192.
24. Radecke F., Billeter M. A. The nonstructural C protein is not essential for multiplication of Edmonston B strain measles virus in cultured cells. Virology. 217:1996;418-421.
25. Radecke F., Spielhofer P., Schneider H., Kaelin K., Huber M., Dotsch C., Christiansen G., Billeter M. A. Rescue of measles viruses from cloned DNA. EMBO J. 14:1995;5773-5784.
26. Roberts A., Kretzschmar E., Perkins A. S., Forman J., Price R., Buonocore L., Kawaoka Y., Rose J. K. Vaccination with a recombinant vesicular stomatitis virus expressing an influenza virus hemagglutinin provides complete protection from influenza virus challenge. J. Virol. 72:1998;4704-4471.
27. Schnell M. J., Buonocore L., Boritz E., Ghosh H. P., Chernish R., Rose J. K. Requirement for a non-specific glycoprotein cytoplasmic domain sequence to drive efficient budding of vesicular stomatitis virus. EMBO J. 17:1998;1289-1296.
28. Schnell M. J., Buonocore L., Kretzschmar E., Johnson E., Rose J. K. Foreign glycoproteins expressed from recombinant vesicular stomatitis viruses are incorporated efficiently into virus particles. Proc. Natl. Acad. Sci. USA. 93:1996a;11359-11365.
29. Schnell M. J., Buonocore L., Whitt M. A., Rose J. K. The minimal conserved transcription stop-start signal promotes stable expression of a foreign gene in vesicular stomatitis virus. J. Virol. 70:1996b;2318-2323.
30. Schnell M. J., Johnson J. E., Buonocore L., Rose J. K. Construction of a novel virus that targets HIV-1-infected cells and controls HIV-1 infection. Cell. 90:1997;849-857.
31. Schneider H., Kaelin K., Billeter M. A. Recombinant measles viruses defective for RNA editing and V protein synthesis are viable in cultured cells. Virology. 227:1997;314-322.
32. Schnell M. J., Mebatsion T., Conzelmann K. K. Infectious rabies viruses from cloned cDNA. EMBO J. 13:1994;4195-4203.
33. Takada A., Robison C., Goto H., Sanchez A., Murti K. G., Whitt M. A., Kawaoka Y. A system for functional analysis of Ebola virus glycoprotein. Proc. Natl. Acad. Sci. USA. 94:1997;14764-14769.
34. Wertz G. W., Perepelista V. P., Ball L. A. Gene rearrangement attenuates expression and lethality of a nonsegmented negative strand RNA virus. Proc. Natl. Acad. Sci. USA. 95:1998;3501-3506.
35. Whelan S. P., Ball L. A., Barr J. N., Wertz G. T. Efficient recovery of infectious vesicular stomatitis virus entirely from cDNA clones. Proc. Natl. Acad. Sci. USA. 92:1995;8388-8392.
36. Yu D., Shioda T., Kato A., Hasan M. K., Sakai Y., Nagai Y. Sendai virus-based expression of HIV-1 gp120: reinforcement by the V(-) version. Genes Cells. 2:1997;457-466.